|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 601 13th St., NW |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20005-2000 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 46676-12
|
||||||||
|
6. House ID# 395790000
|
TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: AMY E. MODLIN |
Date | 7/18/2019 4:17:58 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Point of Sale; Opioids; Sober Homes; Marketplace Stability; Individual Market Reform; CREATES Act; Sec. 1332 Waivers; Short Term Limited Duration (STLD): AHPs; Value-based Care; Health Care Costs; Mental Health; Small Business Plans; Reinsurance; CSRs; FEHBP Issues; Transparency; Silverloading; Health IT; Interoperability; Surprise billing, Transparency, Small Business, State Flexibility; Biosimilars; Provider Directories; Postal Reform; Health Reimbursement Arrangements (HRAs)Outreach, Education, and Enrollment; Prior Authorization; All payer claims database; Negotiated rate disclosure; Provider directories; Medicare for All; Medicare Buy-in
H.R.1346 - 116th Congress (2019-2020)
Medicare Buy-In and Health Care Stabilization Act of 2019
Sponsor: Rep. Higgins, Brian [D-NY-26] (Introduced 02/25/2019)
H.R.1384 - 116th Congress (2019-2020)
Medicare for All Act of 2019
Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 02/27/2019)
H.R.3502 - 116th Congress (2019-2020)
Protecting People From Surprise Medical Bills Act
Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 06/26/2019) Cosponsors: (48)
H.R.2003 - 116th Congress (2019-2020)
Ensuring FEHBP Coverage During Shutdowns Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 04/01/2019)
H.R.987 - Strengthening Health Care and Lowering Prescription Drug Costs Act
116th Congress (2019-2020)
Sponsor: Rep. Blunt Rochester, Lisa [D-DE-At Large] (Introduced 02/06/2019)
H.R.1010 - 116th Congress (2019-2020)
To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect.
Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/06/2019)
H.R.986 - 116th Congress (2019-2020)
Protecting Americans with Preexisting Conditions Act of 2019
Sponsor: Rep. Kuster, Ann M. [D-NH-2] (Introduced 02/06/2019)
H.R.1425 - 116th Congress (2019-2020)
State Health Care Premium Reduction Act
Sponsor: Rep. Craig, Angie [D-MN-2] (Introduced 02/28/2019)
H.R.1143 - 116th Congress (2019-2020)
Pg. 3 of 8
Educating Consumers on the Risks of Short-Term Plans Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 02/11/2019)
H.R.1520 - 116th Congress (2019-2020)
Purple Book Continuity Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 03/05/2019)
S.1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 06/19/2019)
17.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Medicare Advantage; Medicare Prior Authorization; Medicaid Rebates; Medicaid Expansion; Medicaid General; CHIP Reform; MACRA; Rate Notice and Call Letter; Medicare Part D; Medicaid Alignment; NBPP, Part D Donut Hole, Rx Rebates; Medicare Data Sharing; Privacy;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Health Insurance Tax (HIT Tax); Tax Credits; Cadillac Tax; Health Reimbursement Arrangements (HRAs); Sec. 833
S.172 - 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Sen. Gardner, Cory [R-CO] (Introduced 01/16/2019)
S.684 - 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Sen. Heinrich, Martin [D-NM] (Introduced 03/06/2019)
H.R.748 - 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Rep. Courtney, Joe [D-CT-2] (Introduced 01/24/2019)
H.R.1398 - 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Rep. Bera, Ami [D-CA-7] (Introduced 02/27/2019)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Opioids (Epidemic, Deterrence, Economic Impact Zones); CREATES Act;Drug Pricing; PBM/Prescription Drug Costs Rx Rebates; Direct-to-Consumer Rx Advertising;Rx Rebates; Biosimilars; Drug approval;
H.R.1520 - 116th Congress (2019-2020)
Purple Book Continuity Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18]
H.R.1503 - 116th Congress (2019-2020)
Orange Book Transparency Act of 2019
Sponsor: Rep. Kelly, Robin L. [D-IL-2]
H.R.1499 - 116th Congress (2019-2020)
Protecting Consumer Access to Generic Drugs Act of 2019
Sponsor: Rep. Rush, Bobby L. [D-IL-1]
H.R.965 - 116th Congress (2019-2020)
CREATES Act of 2019
Sponsor: Rep. Cicilline, David N. [D-RI-1]
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |